Quarterly report pursuant to Section 13 or 15(d)

Commitments and contingencies (Details Narrative)

v3.22.2
Commitments and contingencies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 27, 2021
Sep. 06, 2018
Mar. 17, 2017
Jun. 30, 2020
Jun. 30, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Law suit filing date         May 28, 2019
G Farma Labs Limited [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sale leaseback transaction, net book value       $ 622,670  
Loss contingency receivable, proceeds       $ 249,481  
Notes Purchase Agreement [Member] | G Farma Labs Limited [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Purchase of secured promissory notes     $ 500,000    
Increased aggregate principal face amount     1,100,000    
Monthly payments     10,239    
Ballon payments on notes     $ 894,172    
Equity Purchase and Issuance Agreement [Member] | G Farma Labs Limited [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Equal interest percentage   3.75%      
Description of equity interests issuable to acquire the entity   On March 4, 2019, Addendum VIII increased the G Farma Equity Entities’ equity interest to which Mentor is immediately entitled to 3.843%, and added Goya Ventures, LLC as a G Farma Equity Entity      
Settlement Agreement And Mutual Release [Member] | G Farma [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Liability for unpaid claims and claims adjustment expense schedule, discussion The Settlement Agreement requires the G Farma Entities to pay the Company an aggregate of $500,000 plus interest, payable monthly as follows: (i) $500 per month for 12 months beginning on September 5, 2021, (ii) $1,000 per month for 12 months beginning September 5, 2022, (iii) $2,000 per month for 12 months beginning September 5, 2023, and (iv) increasing by an additional $1,000 per month on each succeeding September 5th thereafter, until the settlement amount and accrued unpaid interest is paid in full. Interest on the unpaid balance shall initially accrue at the rate of 4.25%, commencing February 25, 2021, and shall be adjusted on February 25th of each year to equal the Prime Rate as published in the Wall Street Journal plus 1%.        
Liability for unpaid claims and claims adjustment expense, net $ 500,000        
Liability for unpaid claims and claims adjustment expense, adjustments $ 2,000,000